company background image
002755 logo

Beijing Aosaikang Pharmaceutical SZSE:002755 Stock Report

Last Price

CN¥14.48

Market Cap

CN¥13.4b

7D

14.7%

1Y

67.6%

Updated

19 Oct, 2024

Data

Company Financials +

Beijing Aosaikang Pharmaceutical Co., Ltd.

SZSE:002755 Stock Report

Market Cap: CN¥13.4b

Beijing Aosaikang Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Aosaikang Pharmaceutical
Historical stock prices
Current Share PriceCN¥14.48
52 Week HighCN¥14.97
52 Week LowCN¥6.50
Beta0.41
11 Month Change33.58%
3 Month Change42.10%
1 Year Change67.59%
33 Year Change15.38%
5 Year Change-3.14%
Change since IPO13.04%

Recent News & Updates

Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking

Oct 18
Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Oct 11
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem

Sep 05
Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem

Recent updates

Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking

Oct 18
Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Oct 11
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem

Sep 05
Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem

Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

May 21
Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

Apr 29
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Mar 13
There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Shareholder Returns

002755CN PharmaceuticalsCN Market
7D14.7%1.6%2.7%
1Y67.6%0.7%4.6%

Return vs Industry: 002755 exceeded the CN Pharmaceuticals industry which returned 0.7% over the past year.

Return vs Market: 002755 exceeded the CN Market which returned 4.6% over the past year.

Price Volatility

Is 002755's price volatile compared to industry and market?
002755 volatility
002755 Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement7.5%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 002755 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002755's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003979Jingfei Mawww.ask-pharm.com

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas.

Beijing Aosaikang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Beijing Aosaikang Pharmaceutical's earnings and revenue compare to its market cap?
002755 fundamental statistics
Market capCN¥13.44b
Earnings (TTM)CN¥85.52m
Revenue (TTM)CN¥1.65b

157.2x

P/E Ratio

8.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002755 income statement (TTM)
RevenueCN¥1.65b
Cost of RevenueCN¥309.16m
Gross ProfitCN¥1.35b
Other ExpensesCN¥1.26b
EarningsCN¥85.52m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 31, 2024

Earnings per share (EPS)0.092
Gross Margin81.31%
Net Profit Margin5.17%
Debt/Equity Ratio2.3%

How did 002755 perform over the long term?

See historical performance and comparison